Agilent Technologies has introduced a suite of electronics and software products designed for use with existing nuclear MR spectroscopy systems.
A new magnetic resonance spectroscopy (MRS) technique may offer a method to detect and track a protein associated with a genetic mutation in brain tumor cancer cells. The method could inform diagnosis of glioma and provide prognostic information, according to a study published online Jan. 26 in Nature Medicine.
Agilent Technologies and the University of Technology, Sydney in Australia have established a joint nuclear MR research facility.
Near-infrared spectroscopy provides rapid, automated detection of extensive lipid-core plaques that are associated with a high risk of periprocedural MI, presumably due to embolization of plaque contents during coronary intervention, according to a substudy of the COLOR registry, published in the October issue of Circulation: Cardiovascular Interventions.
Researchers from the University of California, Davis have modified iPhones and transformed them into devices able to provide near medical-quality images and used them to perform detailed microscopy and spectroscopy. The team will present their findings at the Optical Society’s Annual Meeting, Frontiers in Optics 2011, in San Jose, Calif., Oct. 16-20.
Measuring bone marrow cellularity is typically done using a biopsy of the iliac crest, but a recent study published in the
Journal of Nuclear Medicine indicates that MRI images may also adequately, and noninvasively, measure in vivo bone marrow cellularity.
